Dominant-negative SOX9 mutations in campomelic dysplasia

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Campomelic dysplasia (CD) is a severe skeletal disorder.
• It is typically caused by heterozygous loss-of-function mutations in the SOX9 gene.
• Previous research assumed CD results from SOX9 haploinsufficiency.

Purpose of the Study:

• To investigate novel SOX9 mutations in Campomelic dysplasia.
• To elucidate the molecular mechanism of disease caused by these mutations.

Main Methods:

• Identification of distal truncating SOX9 mutations in four unrelated CD patients.
• Analysis of truncated SOX9 protein synthesis in cultured chondrocytes.
• Assessment of transactivation activity on the COL2A1 gene.

Main Results:

• Four unrelated CD cases with distal truncating SOX9 mutations were identified.
• Truncated SOX9 proteins were synthesized in patient-derived chondrocytes.
• These mutations resulted in decreased COL2A1 transactivation, indicating a dominant-negative effect.
• One case presented with a particularly severe form of CD affecting vertebral and limb development.

Conclusions:

• Distal truncating SOX9 mutations represent a novel molecular mechanism in Campomelic dysplasia.
• The truncated SOX9 protein exerts a dominant-negative effect, leading to a distinct and severe phenotype.
• This finding expands the understanding of SOX9's role in skeletal development and CD pathogenesis.